Skip to content

Drug interactions

Golimumab + Influenza virus vaccine quadrivalent adjuvanted

Severity: Moderate

Golimumab and Influenza virus vaccine quadrivalent adjuvanted: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Golimumab, a TNF blocker, may blunt the antibody response to inactivated influenza vaccine. The vaccine is not harmful in this setting, but protection may be lower than expected in treated patients.

What this interaction means in plain words

Golimumab and Influenza virus vaccine quadrivalent adjuvanted can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

TNF inhibition dampens immune activation and antibody production after vaccination.

What to do

Continue to give inactivated influenza vaccine annually to patients on golimumab, ideally before starting therapy when feasible. Do not rely on vaccination alone and use standard infection-prevention measures.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Golimumab and Influenza virus vaccine quadrivalent adjuvanted, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Golimumab with Influenza virus vaccine quadrivalent adjuvanted?

MediHelp rates the interaction as moderate. Golimumab and Influenza virus vaccine quadrivalent adjuvanted can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Golimumab, a TNF blocker, may blunt the antibody response to inactivated influenza vaccine. The vaccine is not harmful in this setting, but protection may be lower than expected in treated patients.

How serious is the interaction between Golimumab and Influenza virus vaccine quadrivalent adjuvanted?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Continue to give inactivated influenza vaccine annually to patients on golimumab, ideally before starting therapy when feasible. Do not rely on vaccination alone and use standard infection-prevention measures.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in